Dr. Shiela Haffar, M.D.
What this data tells you about Dr. Haffar
Dr. Shiela Haffar is an emergency medicine in Mesquite, TX, with 19 years in practice. Based on federal Medicare data, Dr. Haffar performed 30,604 Medicare services across 2,556 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haffar received a total of $4,385 from 27 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in emergency medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haffar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 7,010 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 6,300 | $0 | $5 |
| Iron sucrose injection (Venofer) | 5,600 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 5,000 | $43 | $137 |
| Complete blood count (CBC) with differential | 855 | $8 | $36 |
| Dexamethasone injection (steroid) | 834 | $0 | $1 |
| Blood draw (venipuncture) | 782 | $8 | $20 |
| Anti-nausea injection (Aloxi/palonosetron) | 490 | $1 | $114 |
| Comprehensive metabolic blood panel | 421 | $10 | $64 |
| Injection, granisetron hydrochloride, 100 mcg | 400 | $0 | $24 |
| Office visit, established patient (20-29 min) | 321 | $61 | $250 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 240 | $79 | $1,348 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 223 | $269 | $2,762 |
| Office visit, established patient (30-39 min) | 182 | $90 | $368 |
| Office visit, established patient (10-19 min) | 158 | $37 | $150 |
| Administration of chemotherapy into vein, 1 hour or less | 126 | $97 | $707 |
| Reticulated (young) platelet measurement | 123 | $35 | $143 |
| Ferritin level test (iron stores) | 120 | $13 | $60 |
| Iron level test | 117 | $6 | $27 |
| Iron binding capacity test | 117 | $9 | $35 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 112 | $173 | $700 |
| Injection of additional new drug or substance into vein | 111 | $11 | $108 |
| Microscopic examination for white blood cells with manual cell count | 88 | $4 | $22 |
| Complete blood count (CBC), automated | 88 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 85 | $22 | $157 |
| Drug injection, under skin or into muscle | 73 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 64 | $49 | $313 |
| Lactate dehydrogenase (enzyme) level | 49 | $6 | $31 |
| Injection, diphenhydramine hcl, up to 50 mg | 45 | $1 | $7 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 44 | $179 | $700 |
| New patient office visit (30-44 min) | 43 | $68 | $372 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 36 | $1,157 | $4,802 |
| Administration of chemotherapy into vein, each additional hour | 36 | $21 | $161 |
| Office visit, established patient, complex (40-54 min) | 36 | $131 | $496 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 35 | $91 | $657 |
| Administration of additional new drug or substance into vein, 1 hour or less | 33 | $49 | $344 |
| New patient office visit (45-59 min) | 30 | $111 | $565 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 27 | $22 | $145 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 25 | $16 | $100 |
| Administration of additional new drug or substance into vein using push technique | 24 | $39 | $289 |
| Unclassified drugs | 24 | $1 | $8 |
| Irrigation of implanted venous access drug delivery device | 23 | $14 | $114 |
| New patient office visit, complex (60-74 min) | 20 | $134 | $709 |
| Application of on-body injector for under skin injection | 17 | $13 | $96 |
| Drawing of blood for a medical problem | 17 | $64 | $264 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for emergency medicine in TX.
Geographic Context
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Haffar is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (consulting-driven, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Haffar experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Haffar receive payments from pharmaceutical companies?
How do Dr. Haffar's costs compare to other emergency medicines in Mesquite?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology